This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2f8g
From Proteopedia
(Difference between revisions)
| Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
| - | 2F8G is a | + | 2F8G is a 2 chains structure of sequences from [http://en.wikipedia.org/wiki/Human_immunodeficiency_virus_1 Human immunodeficiency virus 1]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2F8G OCA]. |
==Reference== | ==Reference== | ||
| - | + | <ref group="xtra">PMID:16480273</ref><references group="xtra"/> | |
[[Category: HIV-1 retropepsin]] | [[Category: HIV-1 retropepsin]] | ||
[[Category: Human immunodeficiency virus 1]] | [[Category: Human immunodeficiency virus 1]] | ||
| - | [[Category: Single protein]] | ||
[[Category: Kovalevsky, A Y.]] | [[Category: Kovalevsky, A Y.]] | ||
[[Category: Weber, I T.]] | [[Category: Weber, I T.]] | ||
[[Category: Hiv-1 protease-inhibitor complex]] | [[Category: Hiv-1 protease-inhibitor complex]] | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Feb 16 15:17:31 2009'' |
Revision as of 13:17, 16 February 2009
HIV-1 protease mutant I50V complexed with inhibitor TMC114
Template:ABSTRACT PUBMED 16480273
About this Structure
2F8G is a 2 chains structure of sequences from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.
Reference
- Kovalevsky AY, Tie Y, Liu F, Boross PI, Wang YF, Leshchenko S, Ghosh AK, Harrison RW, Weber IT. Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M. J Med Chem. 2006 Feb 23;49(4):1379-87. PMID:16480273 doi:http://dx.doi.org/10.1021/jm050943c
Page seeded by OCA on Mon Feb 16 15:17:31 2009
